CompletedPhase 2NCT00345605

Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder

Studying Argininosuccinic aciduria

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Brendan Lee
Principal Investigator: Brendan Lee, MD, PhD
Baylor College of Medicine
Intervention: Sodium Phenylbutyrate(drug)
Enrollment: 12 enrolled
Eligibility: 5 years · All sexes
Timeline: 2008 – 2012

Study locations (1)

Baylor College of Medicine, Houston, Texas, United States

Collaborators

Office of Rare Diseases (ORD) · Rare Diseases Clinical Research Network · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00345605 on ClinicalTrials.gov

← Back to all trials